IGF2BP3 and renal cell carcinoma: Gu et al. [79] showed that the lncRNA DMDRMR can identify m6A modification sites on the target genes by binding to IGF2BP3, enhancing the stability of CDK4 mRNA, and promoting RCC cell proliferation, invasion, and migration (Fig. 4B).